DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Methimazole for Graves’ Disease Linked to Acute Pancreatitis
The treatment of Graves’ disease with the antithyroid drug methimazole is associated with a significantly increased risk of acute pancreatitis, and although cases are rare, the risk justifies warnings about this potential adverse event, according to a nationwide controlled study in Denmark spanning more than 20 years.
“The data are very strong and convincing, (showing) that the risk of pancreatitis is of the same order as that of agranulocytosis, which we have warned against and informed about for decades,” first author Laszlo Hegedus, MD, president of the European Thyroid Association, told Medscape Medical News.
“So not taking this seriously would be extremely arrogant,” he said after presenting his findings at the 89th American Thyroid Association (ATA) Annual Meeting.


Related Content
-
Evidence & Education792: Role of TSIG in Maternal Graves’ Disease for Prediction of Neonatal Thyroid DysfunctionObjective: To determine the impact of m...
-
Evidence & EducationImpaired Immune Regulation After Radioiodine Therapy for Graves’ Disease and the Protective Effect of Methimaz...Both therapies for Graves' disease (GD),...
-
Evidence & EducationAssessing American Thyroid Association Guidelines for Total Thyroidectomy in Graves’ DiseaseBackground: The American Thyroid Associ...
-
Evidence & EducationYour Guide to Understanding Graves’ DiseaseGraves disease is a condition that affec...
-
Evidence & EducationSubstituting Potassium Iodide for Methimazole as the Treatment for Graves’ Disease During the First Trimester ...Background: To control hyperthyroidism ...
-
Evidence & EducationConversion to Graves’ Disease from Hashimoto Thyroiditis: A Study of 24 patientsObjective: The conversion of Hashimoto'...
-
Evidence & EducationAccommodating Employees With Graves’ DiseasePeople with Grave's disease may develop ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.